Presentation

Trends in P2Y12 Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After PCI, 2008-2016

May 21, 2018

REGISTER for free or LOG IN to view this content

Trends in P2Y12 Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After PCI, 2008-2016

Coronary

CAD Pharma

ACS/AMI

Factoid

P2Y12 inhibitor

Antiplatelet Therapy

Up Next

Presentation EuroPCR 2018

PCI Statement on PCI Treatment for Chronic Coronary Syndrome

Presenter: Michael Haude

May 22, 2018

More slides +

Presentation EuroPCR 2018

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

Presenter: Frederik M. Zimmermann

May 23, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.